Apogee Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
APGE Nasdaq 2830 www.apogeetherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Apogee Therapeutics, Inc.

Is AbbVie (ABBV) Undervalued As It Expands Skyrizi In Crohns Disease? - Aug 29th, 2026 7:07 pm
AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026? - Aug 29th, 2026 1:35 pm
AbbVie Defends Its Turf, But Leaves One Big Question Open - Aug 14th, 2026 3:22 pm
Johnson & Johnson vs AbbVie: Safe Dividend vs Higher Yield - Aug 12th, 2026 12:30 pm
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026? - Aug 11th, 2026 2:47 pm
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry? - Aug 11th, 2026 5:05 am
AbbVie (ABBV) Is Down 5.3% After Raising 2026 Revenue Outlook and Issuing New Debt - What's Changed - Aug 7th, 2026 2:14 pm
Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout - Aug 5th, 2026 6:17 am
Sector Update: Healthcare Stocks Softer Late Afternoon - Aug 4th, 2026 1:44 pm
Is Apogee Therapeutics (APGE) Fully Priced, Or Still A Bargain? - Aug 3rd, 2026 1:08 pm
AbbVie Earnings Beat Forecasts as Skyrizi Sales Soar 24%. Why the Stock Is Falling. - Jul 31st, 2026 11:22 am
AbbVie Trims Full-Year Profit Outlook Due to Apogee Acquisition - Jul 31st, 2026 9:45 am
AbbVie Q2 Earnings Call Highlights - Jul 31st, 2026 9:04 am
AbbVie Q2 2026 earnings: profit forecast cut for Apogee deal - Jul 31st, 2026 7:20 am
AbbVie shares fall on earnings miss and weak guidance - Jul 31st, 2026 6:27 am
Botox Maker Tops Buy Point, But Here Comes The Earnings Report - Jul 28th, 2026 12:40 pm
Is Apogee Therapeutics Inc. (APGE) Stock Outpacing Its Medical Peers This Year? - Jul 28th, 2026 7:40 am